Dr. Anne Wyllie

Yale School of Public Health

Revolutionary saliva-based assays use pandemic learnings to advance respiratory virus diagnostics

Dr. Anne Wyllie is a research scientist at the Yale School of Public Health, and principal investigator of the SalivaDirect Initiative. In this video interview, Wyllie describes how her team is currently working to expand the saliva-based assay, SalivaDirect, which they developed for SARS-CoV-2. Using their learnings during the COVID pandemic, Wyllie describes how the assay has now been updated to also target other respiratory pathogens. Wyllie also discusses the interdisciplinary network of partners that have come together throughout the pandemic response, and the importance of continuing collaborations like this in the future.



LIKE 0


Dr. Anne Wyllie
Genetic Analysis Health Sciences

Dr. Anne Wyllie

Biography

Dr. Anne Wyllie, Research Scientist, Yale School of Public Health and Principal Investigator, SalivaDirect More

Dr. Anne Wyllie

Yale School of Public Health

Dr. Anne Wyllie completed a BSc in Biomedical Science at the University of Auckland in 2007, followed by a Postgraduate Diploma, and Masters in Medical Science in 2009 at the Auckland Cancer Society Research Centre (University of Auckland). Wyllie completed a Ph.D. in medical microbiology in 2016 at Utrecht University. Since early 2020, she has worked as a research scientist in the Department of Epidemiology of Microbial Diseases at the Yale School of Public Health at Yale University and she is the Principal Investigator of SalivaDirect.